Target intelligence / Profile preview

D-ornithine 4,5-aminomutase (OAM)

Target
OAM
Molecular classification
Enzyme, Isomerase, Aminomutase, Adenosylcobalamin-dependent enzyme, Pyridoxal phosphate-dependent enzyme
01

Overview

D-ornithine 4,5-aminomutase (OAM) is a specialized bacterial enzyme responsible for the anaerobic fermentation of amino acids in various microorganisms, including the human pathogen Clostridioides difficile [UniProt, PMID: 28325765]. It catalyzes the reversible intramolecular migration of the delta-amino group of D-ornithine to the C4 position, producing (2R,4S)-2,4-diaminopentanoate [PMID: 18997010, 21899873]. This complex transformation involves a radical-based mechanism that requires two essential cofactors: adenosylcobalamin (coenzyme B12), which generates the initiating 5'-deoxyadenosyl radical, and pyridoxal 5'-phosphate (PLP), which stabilizes the substrate as a Schiff base [PMID: 18997010, 21899873]. Structurally, the enzyme typically exists as a heterotetramer composed of alpha and beta subunits, often designated as OraS and OraE [UniProt, PMID: 18997010]. Because OAM is vital for the metabolic fitness of anaerobic pathogens and is absent in humans, it is viewed as a potential target for the development of selective anti-infective agents [PMID: 28325765]. Experimental inhibitors like 2,4-diaminobutyric acid (DAB) disrupt the catalytic cycle by forming stable radical intermediates that prevent enzyme turnover [PMID: 21899873].

Other names
Ornithine 4,5-aminomutaseD-ornithine aminomutaseD-ornithine 5,4-aminomutaseORAOraEOraS
02

Mechanism of action

Radical-mediated 1,2-migration of the delta-amino group of D-ornithine to the C4 position using adenosylcobalamin and pyridoxal phosphate cofactors; suicide inhibition occurs through the formation of overstabilized radical intermediates.

03

Biological functions

Amino acid metabolismD-ornithine fermentationIntramolecular amino group migrationRadical-mediated catalysis
04

Disease associations

InfectionClostridioides difficile infection
05

Safety considerations

Microbiome dysbiosisPotential interference with host vitamin B12 metabolism if not selective
06

Interacting drugs

2,4-diaminobutyric acid
07

Biomarkers

(2R,4S)-2,4-diaminopentanoate

Beyond the preview

Go deeper on D-ornithine 4,5-aminomutase (OAM).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on D-ornithine 4,5-aminomutase (OAM).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call